Simbrinza Opthalmic Suspension

Aperçu du produit

About Simbrinza Opthalmic

Simbrinza Opthalmic is a medication containing the active ingredient Brinzolamide, classified as Carbonic Anhydrase Inhibitor. Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Brinzolamide, the active ingredient in Simbrinza Opthalmic, belongs to the Carbonic Anhydrase Inhibitor class. 1 INDICATIONS AND USAGE AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Simbrinza Opthalmic. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Simbrinza Opthalmic for extended periods without medical advice.